Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash Flows From Operating Activities:
Net income	$ 234,196	$ 291,190	$ 256,513
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	154,208	152,620	148,660
Amortization of debt issuance costs and discounts	6,131	6,234	6,419
Loss on early extinguishment of debt and write-off of discounts and debt issuance costs			52,011
Deferred income tax provision (benefit)	72,636	95,487	(4,117)
Equity-based compensation	17,032	18,158	39,722
Other including loss on impairment or disposal of assets, net	30,523	15,280	5,816
Changes in assets and liabilities:
Accounts receivable	(4,528)	10,334	(58,927)
Inventories	5,366	(27,112)	644
Prepaid expenses and other current assets	9,448	(7,020)	(2,424)
Accounts payable and accrued expenses	(8,887)	7,849	20,050
Accrued salaries, wages and benefits	3,781	(4,733)	11,375
Deferred revenue	(13,953)	329	33,070
Other accrued liabilities	5,608	1,961	(3,785)
Right-of-use assets and operating lease liabilities	439	580	396
Other assets and liabilities	(7,084)	3,431	(2,411)
Net cash provided by (used in) operating activities	504,916	564,588	503,012
Cash Flows From Investing Activities:
Capital expenditures	(304,836)	(200,705)	(128,854)
Other investing activities	(771)
Net cash used in investing activities	(305,607)	(200,705)	(128,854)
Cash Flows From Financing Activities:
Proceeds from the issuance of debt, net			1,922,222
Repayments of long-term debt	(12,000)	(12,000)	(2,032,728)
Proceeds from draw on revolving credit facility	20,000
Repayments of revolving credit facility	(20,000)
Purchase of treasury stock	(17,861)	(693,623)	(215,749)
Payment of tax withholdings on equity-based compensation through shares withheld	(6,859)	(22,501)	(14,506)
Exercise of stock options	2,940	3,028	5,907
Debt issuance costs		(469)	(23,272)
Other financing activities	(927)	(484)	(6,771)
Net cash (used in) provided by financing activities	(34,707)	(726,049)	(364,897)
Change in Cash and Cash Equivalents, including Restricted Cash	164,602	(362,166)	9,261
Cash and Cash Equivalents, including Restricted Cash—Beginning of year	82,320	444,486	435,225
Cash and Cash Equivalents, including Restricted Cash—End of year	246,922	82,320	444,486
Supplemental Disclosures of Noncash Investing and Financing Activities
Capital expenditures in accounts payable and accrued expenses	$ 50,618	$ 40,729	20,468
Other financing arrangements			$ 4,239